Moving CAR-Ts to the outpatient clinic

Gabriela A. Llaurador, Helen E. Heslop, David H. Steffin

Research output: Contribution to journalComment/debatepeer-review


As centres obtain more experience with commercial CARs, there has been increasing interest in trying to move as much as the procedure as possible to the outpatient clinic to reduce costs, maximize reimbursement and increase patient satisfaction. The report by Ly et al. details how their centre implemented outpatient CAR therapy and were able to reduce admission time without affecting outcomes. Commentary on: Ly et al. Outpatient CD19-directed CAR T-cell therapy is feasible in patients of all ages. Br J Haematol 2023;203:688-692.

Original languageEnglish (US)
Pages (from-to)507-508
Number of pages2
JournalBritish Journal of Haematology
Issue number4
StatePublished - Nov 2023


  • CAR T cell infusion
  • CD19
  • outpatient lymphodepletion

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Moving CAR-Ts to the outpatient clinic'. Together they form a unique fingerprint.

Cite this